Treatment of indiscriminate, inappropriate sexual behavior in frontotemporal dementia with carbamazepine

Journal of Clinical Psychopharmacology

Volumn 32, Issue 1, 2012, Pages 137-138

  Poetter, Connie E ^a   Stewart, Jonathan T ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ATENOLOL; CARBAMAZEPINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; WARFARIN;

AGED; ANAMNESIS; ATAXIA; BEHAVIOR THERAPY; BLOOD DYSCRASIA; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DRUG DOSE TITRATION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; FRONTOTEMPORAL DEMENTIA; HUMAN; HYPERSEXUALITY; HYPERTENSION; HYPONATREMIA; INSTITUTIONALIZATION; KLUVER BUCY SYNDROME; LETTER; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; SEDATION; SEXUAL BEHAVIOR; SEXUAL DEVIATION; SIDE EFFECT; STEVENS JOHNSON SYNDROME; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; ANTICONVULSANTS; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FRONTOTEMPORAL DEMENTIA; HUMANS; KLUVER-BUCY SYNDROME; MALE; SEXUAL BEHAVIOR;

EID: 84855398702     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31823f91b9     Document Type: Letter

References (14)

1. Levitsky AM, Owens NJ. Pharmacologic treatment of hypersexuality and paraphilias in nursing home residents. J Am Geriatr Soc. 1999;47:231-234. (Pubitemid 29082725)
2. Tucker I. Management of inappropriate sexual behaviors in dementia: a literature review. Int Psychogeriatr. 2010;22: 683-692.
3. Steele C, Rovner B, Chase GA, et al. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry. 1990;147: 1049-1051. (Pubitemid 20257519)
4. Black B, Muralee S, Tampi RR. Inappropriate sexual behaviors in dementia. J Geriatr Psychiatry Neurol. 2005;18:155-162. (Pubitemid 41284966)
5. Guay DRP. Inappropriate sexual behaviors in cognitively impaired older individuals. Am J Geriatr Pharmacother. 2008;6: 269-288.
6. Stewart JT. Behavioral and emotional complications of neurological disorders. In: Noseworthy JH, ed. Neurological Therapeutics: Principles and Practice. 2nd ed. Abingdon, UK: Informa Healthcare; 2006:3207-3222.
7. Hooshmand H, Sepdham T, Vries JK. Klüver-Bucy syndrome: successful treatment with carbamazepine. JAMA. 1974;229:1782.
8. Lilly R, Cummings JL, Benson DF, et al. The human Klüver-Bucy syndrome. Neurology. 1983;33: 1141-1145.
9. Klüver H, Bucy PC. Psychic blindness and other symptoms following bilateral temporal lobectomy in rhesus monkeys. Am J Physiol 1937;119:352-353.
10. Kertesz A, Munoz DG. Frontotemporal dementia. Med Clin North Am. 2002;86: 501-518. (Pubitemid 34810645)
11. Spiegel DR, Burgess J, Samuels D, et al. Disinhibition due to disruption of the orbitofrontal circuit treated successfully with carbamazepine: a case series. J Neuropsychiatry Clin Neurosci. 2009;21:323-327.
12. Freymann N, Michael R, Dodel R, et al. Successful treatment of sexual disinhibition in dementia with carbamazepine. Pharmacopsychiatry. 2005;38: 144-145. (Pubitemid 40965969)
13. Stewart JT. Carbamazepine treatment of a patient with Klüver-Bucy syndrome. J Clin Psychiatry. 1985;46:496-497. (Pubitemid 16234471)
14. Goscinski I, Kwiatkowski S, Polak J, et al. The Klüver-Bucy syndrome. Acta Neurochir (Wien). 1997;139:303-306.